undamentalytics Newsletter

Biote Corp. balance sheet

At the end of fiscal 2025, Biote Corp. had total assets of $108m, total liabilities of $158m and shareholders' equity of −$58.5m. It held $24.1m in cash against $103m of debt: net debt of $79.0m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Biote Corp.: balance sheet, annual
Fiscal year2021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Cash and equivalents07989392411
Receivables577878
Inventory101117151918
Total current assets47101122685543
Goodwill———666
Total assets54112155122108102
Accounts payable444677
Deferred revenue (current)223333
Total current liabilities171922524530
Short-term debt566663
Long-term debt3211210710196118
Total debt38122116109103125
Total liabilities50170192225158160
Shareholders' equity4−44−29−106−59−66
Non-controlling interests and other (assets − liabilities − equity)—−14−7488
Net debt (negative = net cash)3743277079114

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: BTMD vs OGIBTMD vs KMDABTMD vs CRONAMRN vs BTMD

More: Pharmaceuticals stocks compared, Health Care sector, rankings of US companies

Figures from Biote Corp.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Biote Corp.